Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Other Non Operating Income (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Other Non Operating Income readings, the most recent being -$461000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 236.5% to -$461000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 7345.16% increase, with the full-year FY2025 number at $2.3 million, up 7348.39% from a year prior.
  • Other Non Operating Income hit -$461000.0 in Q4 2025 for Arcadia Biosciences, down from $1.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $7.5 million in Q1 2021 to a low of -$461000.0 in Q4 2025.
  • Median Other Non Operating Income over the past 5 years was $14000.0 (2022), compared with a mean of $658473.7.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 27490.0% in 2021 and later crashed 1241.67% in 2024.
  • Arcadia Biosciences' Other Non Operating Income stood at -$100000.0 in 2021, then soared by 96.0% to -$4000.0 in 2022, then surged by 400.0% to $12000.0 in 2023, then crashed by 1241.67% to -$137000.0 in 2024, then tumbled by 236.5% to -$461000.0 in 2025.
  • The last three reported values for Other Non Operating Income were -$461000.0 (Q4 2025), $1.7 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.